AtriCure, Inc. (NASDAQ: ATRC) reported Q2 EPS of ($0.10), $0.09 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $26.5 million versus the consensus estimate of $25.03 million.

For earnings history and earnings-related data on AtriCure, Inc. (ATRC) click here.